Cao, Jia
Peng, Jinghua
An, Hongying
He, Qiyi
Boronina, Tatiana
Guo, Shaodong
White, Morris F.
Cole, Philip A.
He, Ling
Article History
Received: 28 November 2016
Accepted: 1 June 2017
First Online: 25 July 2017
Competing interests
: P.A.C. is a co-founder and scientific advisor for Acylin Therapeutics which developed the P300 acetyltransferase inhibitor C646. The remaining authors declare no competing financial interests.